ArticleScientific reports2025
Transperitoneal robotic-assisted versus laparoscopic partial nephrectomy for renal duplication: a comparative clinical analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Advancements and outcomes of robotic-assisted surgery in pediatric patients: a multicenter analysis.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This retrospective study aimed to compare the efficacy and safety of robotic-assisted laparoscopic partial nephrectomy (RALPN) versus laparoscopic partial nephrectomy (LPN) in pediatric patients with renal duplication. Data from 105 pediatric patients who underwent surgery for renal duplication at the Department of Pediatric Surgery, Fujian Provincial Hospital, between January 2019 and March 2024 were reviewed. Patients were categorized into two groups based on surgical approach: RALPN and LPN. The RALPN group had a significantly higher mean age (5.10 ± 2.63 years) compared to the LPN group (2.67 ± 2.16 years, p < 0.001). RALPN patients experienced shorter hospital stay (7.3 ± 1.7 days vs. 9.5 ± 3.3 days, p < 0.001)) and higher hospitalization expenses ($5,723 ± 1,322 vs. $1,787 ± 564, p < 0.001). No significant differences were observed in gender distribution, follow-up duration, BMI, side of surgery, presenting symptoms, coexisting urinary system diseases, or readmission rates between the groups. Intraoperative data showed that RALPN resulted in a trend towards lower blood loss (8.41 ± 3.58 ml vs. 10.73 ± 4.60 ml, p = 0.023) but required a longer total operation time (234.68 ± 58.02 min vs. 185.36 ± 54.07 min, p < 0.001). However, the partial nephrectomy duration was shorter in RALPN (125.45 ± 19.27 min vs. 153.49 ± 48.81 min, p < 0.001). RALPN had faster recovery with shorter durations of postoperative hematuria and catheterization. At 12 months post-surgery, RALPN showed significantly lower anteroposterior diameter of renal pelvis and maximum cross-sectional area of the cyst, indicating better preservation of renal function. Both RALPN and LPN are safe and effective for treating renal duplication in pediatric patients. Despite RALPN is associated with higher hospitalization costs, its overall cost-effectiveness may be comparable to LPN due to fewer complications and faster recovery. Further multicenter, randomized controlled trials are warranted to validate these findings and assess long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.